Seppic reveals new clinical data for its product Taladvance

Seppic has reported that new clinical data has found its complexion perfector active ingredient Taladvance enhances skin uniformity and complexion after 30 minutes of application.

Participants of a clinical trial testing the performance of Taladvance observed that their skin felt refreshed and regained homogeneity and glow after 28 days.

According to the Global Truth in Beauty survey by Clinique 2007, some of the main skin concerns for consumers are radiance and complexion.

Taladvance is sourced in Madagascar by Seppic’s subsidiary Serdex, which was acquired by Seppic in January 2017. It produces active ingredients extracted from Malagasy plants.

Taladvance is an Ecocert-certified extract and has a similar molecular composition of the Centella Asiatica plant. One of Taladvance’s key ingredients, this plant is said to protect and maintain skin balance.

Known for its soothing and repairing properties, the Centella Asiatica contains chemical compounds such as triterpenes and polyphenols and is mostly used in dermocosmetic applications.

Seppic has subsidiaries and distributors in more than 100 countries and employs 700 people.